CROMA at ESCRS

Article

During this year?s ESCRS in Vienna CROMA will highlight its history of 35 years as a key player in ophthalmology.

During this year´s ESCRS in Vienna CROMA will highlight its history of 35 years as a key player in ophthalmology. Having started from a small pharmacy, the family-owned company reached the level of big international competitors, constantly developing innovative and unique products for markets all over the world.

Currently, CROMA is performing clinical studies, involving a new product, based on the so-called Thiomers, a unique technology combining macromolecules such as hyaluronic acid to a human amino acid (cysteine) for different ophthalmic applications. First results will be presented during the CROMA satellite symposium.

In the field of intraocular lenses, CROMA is launching two new models in 2011. The new hydrophobic blue-light filtering IOL “EYE-Cee One” has been successfully introduced in May. First clinical experiences will be shared during the ESCRS lunch symposium. CROMA will further make use of the ESCRS in Vienna to internationally launch its new multifocal IOL.

CROMA satellite symposium:

“Amazing Advances in Ocular Excellence”
Sunday, 18th September, 2011
1:00 pm – 2:00 pm
Room Stolz 1

CROMA - Bausch and Lomb joint satellite symposium:

“Bromfenac, a new potent Tool in Inflammation Control post cararact surgery”
Sunday, 18th September, 2011
1:00 pm – 2:00 pm
Room Strauss 3

Click here to register online.

Click here to email CROMA

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.